申请人:Icahn School of Medicine At Mount Sinai
公开号:US20220402880A1
公开(公告)日:2022-12-22
A genus of bicyclic inhibitors of CBX chromodomains is disclosed. The compounds are of the following genus:
The compounds inhibit CBX proteins and, as a consequence, they are useful for treating prostate cancer, ovarian cancer, and B-cell lymphoma.